National Bank of Canada’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Buy |
1,333
+365
| +38% | +$20.1K | ﹤0.01% | 1550 |
|
|
2025
Q1 | $68.4K | Sell |
968
-10
| -1% | -$707 | ﹤0.01% | 1491 |
|
|
2024
Q4 | $64.4K | Buy |
978
+59
| +6% | +$3.88K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $64.6K | Sell |
919
-13,464
| -94% | -$946K | ﹤0.01% | 1459 |
|
|
2024
Q2 | $1.18M | Sell |
14,383
-209,522
| -94% | -$17.2M | ﹤0.01% | 917 |
|
|
2024
Q1 | $18.1M | Sell |
223,905
-44,702
| -17% | -$3.62M | 0.03% | 365 |
|
|
2023
Q4 | $26.3M | Sell |
268,607
-342,304
| -56% | -$33.6M | 0.04% | 290 |
|
|
2023
Q3 | $53.2M | Buy |
610,911
+592,585
| +3,234% | +$51.6M | 0.08% | 170 |
|
|
2023
Q2 | $1.57M | Buy |
18,326
+10,385
| +131% | +$892K | ﹤0.01% | 929 |
|
|
2023
Q1 | $768K | Sell |
7,941
-721
| -8% | -$69.7K | ﹤0.01% | 1030 |
|
|
2022
Q4 | $896K | Sell |
8,662
-1,805
| -17% | -$187K | ﹤0.01% | 1006 |
|
|
2022
Q3 | $907K | Sell |
10,467
-2,712
| -21% | -$235K | ﹤0.01% | 888 |
|
|
2022
Q2 | $1.12M | Sell |
13,179
-16,014
| -55% | -$1.36M | 0.01% | 833 |
|
|
2022
Q1 | $2.3M | Buy |
29,193
+17,352
| +147% | +$1.36M | 0.01% | 682 |
|
|
2021
Q4 | $1.03M | Buy |
+11,841
| New | +$1.03M | ﹤0.01% | 898 |
|